iShares U.S. Pharmaceuticals ETF (IHE)

iShares U.S. Pharmaceuticals ETF (IHE $68.43)
- $68.43 P/E (TTM): 63.66X Cap: $541M
- View IHE Profile
- View Questions on IHE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Gilead Sciences Inc. (GILD $120.14)
- $120.14 P/E (TTM): 25.21X Cap: $149.07B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $482.35)
- $482.35 P/E (TTM): 66.6X Cap: $172.91B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $201.47)
- $201.47 P/E (TTM): 84.89X Cap: $355.90B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $174.42)
- $174.42 P/E (TTM): 18.48X Cap: $420.06B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $660.49)
- $660.49 P/E (TTM): 52.03X Cap: $625.12B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $92.91)
- $92.91 P/E (TTM): 25.51X Cap: $119.04B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $378.95)
- $378.95 P/E (TTM): 49.88X Cap: $144.87B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $484.79)
- $484.79 P/E (TTM): 27.61X Cap: $183.06B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $133.29)
- $133.29 P/E (TTM): 65.74X Cap: $32.60B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $61.79)
- $61.79 P/E (TTM): 164.7X Cap: $4.37B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.53)
- $18.53 P/E (TTM): 31.36X Cap: $4.48B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $16.43)
- $16.43 Cap: $5.86B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $68.43)
- $68.43 P/E (TTM): 63.66X Cap: $541M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $20.19)
- $20.19 P/E (TTM): 12.33X Cap: $2.47B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Regeneron Pharmaceuticals Inc. (REGN $561.55)
- $561.55 P/E (TTM): 14.0X Cap: $59.51B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $174.42)
- $174.42 P/E (TTM): 18.48X Cap: $420.06B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $660.49)
- $660.49 P/E (TTM): 52.03X Cap: $625.12B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $82.71)
- $82.71 P/E (TTM): 11.7X Cap: $206.59B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.16)
- $25.16 P/E (TTM): 17.86X Cap: $143.04B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $484.79)
- $484.79 P/E (TTM): 27.61X Cap: $183.06B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $50.90)
- $50.90 P/E (TTM): 14.13X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $137.10)
- $137.10 P/E (TTM): 74.16X Cap: $5.60B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $26.89)
- $26.89 Cap: $10.46B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $164.79)
- $164.79 P/E (TTM): 61.18X Cap: $347M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $68.43)
- $68.43 P/E (TTM): 63.66X Cap: $541M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023

BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $63.90)
- $63.90 P/E (TTM): 82.38X Cap: $186M
- View ZUH Profile
- View Questions on ZUH
iShares Biotechnology ETF (IBB $137.10)
- $137.10 P/E (TTM): 74.16X Cap: $5.60B
- View IBB Profile
- View Questions on IBB
iShares U.S. Medical Devices ETF (IHI $61.79)
- $61.79 P/E (TTM): 164.7X Cap: $4.37B
- View IHI Profile
- View Questions on IHI
iShares U.S. Pharmaceuticals ETF (IHE $68.43)
- $68.43 P/E (TTM): 63.66X Cap: $541M
- View IHE Profile
- View Questions on IHE
iShares Genomics Immunology and Healthcare ETF (IDNA $22.47)
- $22.47 P/E (TTM): 27.51X Cap: $108M
- View IDNA Profile
- View Questions on IDNA

Q: Can you recommend one or more etf's that would provide exposure to the health industry including medical devices, genomics, biotech, big pharma etc. Covered call etf's in these sectors would also be of interest. Thanks

Read Answer Asked by Ian on July 12, 2022